We serve 2-[(S)-(4-chlorophenyl)-piperidin-4-yloxymethyl]pyridine CAS:201594-84-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 2-[(S)-(4-chlorophenyl)-piperidin-4-yloxymethyl]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine Use and application,(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine technical grade,usp/ep/jp grade.
Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”1H,1H,2H,2H-Perfluorodecyltriethoxysilane manufacturer Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”L-Menthyl glyoxylate hydrate supplier Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”5-[2-(methylamino)-5-nitroanilino]-5-oxopentanoic acid vendor It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.